“A Phase 1 Study of Heat/Phenol-Killed, E. coli - Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the Treatment of Peanut Allergy”, Allergy, vol. 68, pp. 803-808, 2013.
, “A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy.”, Allergy, vol. 68, no. 6, pp. 803-8, 2013.
, “Sublingual Immunotherapy for Peanut Allergy: A Randomized, Double-Blind, Placebo Controlled Multicenter Trial”, J Allergy Clin Immunol, vol. 131, pp. 119-127.e1-7, 2013.
, “Atopic Dermatitis Increases the Effect of Exposure to Peanut Antigen in Dust on Peanut Sensitization and Likely Peanut Allergy”, J Allergy Clin Immunol, 2014.
, “The Natural History of Egg Allergy in an Observational Cohort”, J Allergy Clin Immunol, vol. 133, pp. 492-499, 2014.
, “Component-resolved analysis of IgA, IgE, and IgG4 during egg OIT identifies markers associated with sustained unresponsiveness.”, Allergy, vol. 71, no. 11, pp. 1552-1560, 2016.
,